In RA, HDAC6 inhibition induces tubulin hyperacetylation in fibroblast-like synoviocytes (FLS), reducing inflammatory cytokine and tissue-degrading enzyme production [79]. This evidence concerns the gene HDAC6 and rheumatoid arthritis.